Low-Flow Safety

Traditional granular absorbents are known to degrade volatile anesthetics and produce toxic byproducts, including Compound A, Carbon Monoxide, and Formaldehyde, thus preventing clinicians from utilizing low flow anesthesia. Several absorbents have eliminated these concerns by removing KOH and reducing NaOH concentration to <2%.1 However, these changes severely impact product duration and frequency of disposal.

SpiraLith Ca utilizes <1% NaOH and eliminates concern for toxic byproducts. When this chemistry is packaged with Solid Absorbent(r) technology there is no duration penalty. In fact, SpiraLith Ca duration is superior to all granular absorbents.

SpiraLith Ca allows clinicians to safely and cost-effectively utilize low-flow anesthesia and its benefits:1

• Humidification of inspired gasses, resulting in better infection fighting capabilities, higher core body temperatures, less lung damage, and fewer post-operative complications.

• Dramatic reduction of volatile anesthetics and their associated costs.

• Further reduction of volatile anesthetics entering landfills and the environment (disposed canisters contain residual agent)

1 Feldman JM, Hendrickx J, Kennedy R. Carbon Dioxide Absorption During Inhalation Anesthesia: A Modern Practice. Anesthesia & Analgesia. April 2021, Vol. 132, Issue 4, p 993.